Enterprise Value
1.687B
Cash
210.5M
Avg Qtr Burn
-20.92M
Short % of Float
4.97%
Insider Ownership
0.47%
Institutional Own.
86.80%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
FPI-1966 Details Solid tumor/s, Head and neck cancer, Bladder cancer, Cancer | Failed Discontinued |